(Q24791211)

6 July 2017

title

Antitumorigenic Evaluation of Thalidomide Alone and in Combination with Cisplatin in DBA2/J Mice (English)

1 reference

6 July 2017

0 references

1 reference

Jean Marie B. Ruddy

1

1 reference

6 July 2017

Shyamal K. Majumdar

series ordinal

2

1 reference

6 July 2017

language of work or name

1 reference

1 January 2002

1 reference

Journal of Biomedicine and Biotechnology

6 July 2017

published in

1 reference

6 July 2017

volume

2

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

7-13

1 reference

Creative Commons Attribution 3.0 Unported

6 July 2017

copyright license

start time

1 January 2002

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Thalidomide and a thalidomide analogue inhibit endothelial cell proliferation in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Thalidomide: current and potential clinical applications

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Angiogenesis and Cancer Control: From Concept to Therapeutic Trial

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Response of murine erythroleukemia cells to cis- and trans-diamminedichloroplatinum (II).

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Cis-diamminedichloroplatinum (II). A new anticancer drug

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Tumorigenicity of Friend murine erythroleukemia cell lines differing in spontaneous differentiation rates

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

The re-emergence of thalidomide: results of a scientific conference.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Assessment of the in vitro and in vivo genotoxicity of Thalomid (thalidomide).

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=139116

Inhibition of angiogenesis by thalidomide requires metabolic activation, which is species-dependent

28 November 2018

1 reference

12 December 2020

Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease

1 reference

12 December 2020

Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients

1 reference

12 December 2020

Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice

1 reference

12 December 2020

Thalidomide therapy in refractory solid tumour patients

1 reference

12 December 2020

Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistry

1 reference

12 December 2020

Thalidomide and chemotherapy combination

1 reference

12 December 2020

Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats

1 reference

12 December 2020

Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo

1 reference

12 December 2020

Phase II evaluation of thalidomide in patients with metastatic breast cancer

1 reference

12 December 2020

10.1155/S1110724302000359

Identifiers

DOI

1 reference

6 July 2017

1 reference

6 July 2017

1 reference